Embryonic quality in the use of urofolitropin vs recombinant FSH for in vitro fertilization
Contreras Bretherton, C.; David Vargas, R.; Cedillo, F.J.; Vilchez, R.; Das Neves, D.; Bernal, M.A.; Verez Ruíz, J.R.; Stern Colin y Nunes, J.J.; Gutiérrez Nájar, A.
Ginecologia y Obstetricia de Mexico 67: 216-220
1999
ISSN/ISBN: 0300-9041 PMID: 10363424 Document Number: 507506
There were no differences in both groups as tho the age of the patients; received doses of both types of FSH, nor HMG; but there was as to the amount of captured ovocytes, amount, and quality, embrionary, in special 1+ 2+ in favor of the group that received urofolitropine, specially under 35 years of age. In this study there was better qualy and amount, embrionary, obtained with the use of urofolitropine, as compared with FSH recombinant for in vitro fertilization.